Oncoinvent ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	133.67	30.1	196.02
Cash & Short-Term Investments	133.67	30.1	196.02
Cash Growth	344.15%	-84.65%	-
Accounts Receivable	0.45	-	-
Other Receivables	5.38	21.5	13.48
Receivables	5.83	21.5	13.48
Prepaid Expenses	2.78	4.3	3.21
Restricted Cash	2.03	2.03	-
Other Current Assets	-0	-	-
Total Current Assets	144.3	57.92	212.71
Property, Plant & Equipment	26.71	40.81	21.45
Other Long-Term Assets	0	-	-
Total Assets	171.02	98.73	234.16
Accounts Payable	14.74	12.75	7.7
Accrued Expenses	40.48	18.88	20.61
Current Portion of Leases	2.71	3.83	3.19
Other Current Liabilities	0	-	-
Total Current Liabilities	57.94	35.46	31.5
Long-Term Leases	4.74	8.35	8.84
Total Liabilities	62.68	43.8	40.35
Common Stock	9.22	1.94	1.94
Additional Paid-In Capital	726.28	538.15	537.65
Retained Earnings	-636.76	-496.56	-353.08
Comprehensive Income & Other	9.6	11.39	7.31
Shareholders' Equity	108.33	54.93	193.82
Total Liabilities & Equity	171.02	98.73	234.16
Total Debt	7.45	12.17	12.03
Net Cash (Debt)	126.22	17.92	183.99
Net Cash Growth	604.25%	-90.26%	-
Net Cash Per Share	1.37	0.92	9.49
Filing Date Shares Outstanding	92.24	19.39	19.39
Total Common Shares Outstanding	92.24	19.39	19.39
Working Capital	86.36	22.47	181.21
Book Value Per Share	1.17	2.83	9.99
Tangible Book Value	108.33	54.93	193.82
Tangible Book Value Per Share	1.17	2.83	9.99
Land	34.96	33.12	13.24
Machinery	27.26	28.07	21.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.